Koers Gene Biotherapeutics, Inc. Other OTC
Aandelen
CRXM
US8767671048
Biotechnologie & Medisch Onderzoek
Omzet 2019 | - | Omzet 2020 | - | Marktkapitalisatie | 551K 511K |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | - 0 | Nettowinst (verlies) 2020 | - 0 | EV/omzet 2019 | - |
Nettoschuld 2019 | 1,12 mln. 1,04 mln. | Nettoschuld 2020 | 874K 812K | EV/omzet 2020 | - |
K/w-verhouding 2019 |
3,09
x | K/w-verhouding 2020 |
-1,77
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 93,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 70 | 22-12-03 | |
James Grainer
CHM | Chairman | 69 | 22-05-20 |
Lois Chandler
COO | Chief Operating Officer | - | 01-07-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 70 | 22-12-03 | |
James Grainer
CHM | Chairman | 69 | 22-05-20 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 22-05-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,37% | 47,02 mld. | |
+48,83% | 41,86 mld. | |
-0,94% | 41,76 mld. | |
-5,86% | 28,8 mld. | |
+11,29% | 26,05 mld. | |
-20,92% | 19,15 mld. | |
+3,20% | 12,55 mld. | |
-2,67% | 11,82 mld. | |
+30,23% | 12,34 mld. |